Literature DB >> 12969703

Factor XII deficiency is strongly associated with primary recurrent abortions.

Hans-Ulrich Pauer1, Peter Burfeind, Heinz Köstering, Günter Emons, Bernd Hinney.   

Abstract

OBJECTIVE: To evaluate factor XII deficiency in women with primary and secondary recurrent abortion.
DESIGN: Prospective case-control study.
SETTING: University hospital. PATIENT(S): Sixty-seven women with primary and 33 women with secondary recurrent abortion of unexplained nature and 49 healthy controls with no history of thrombotic disease or adverse pregnancy outcomes. MAIL OUTCOME MEASURE(S): Plasma factor XII activity, activated protein C resistance, factor V Leiden mutation analysis, protein C, protein S, antithrombin III, karyotyping, and anticardiolipin antibodies. RESULT(S): Ten of 67 women with primary recurrent abortion (14.9%) and 4 of 33 women (12.1%) with secondary recurrent abortion had reduced factor XII activity (<60%). These results are highly significant in the former group and showed a tendency toward significance in the latter group. All controls had normal factor XII activity. CONCLUSION(S): Factor XII deficiency is strongly associated with primary recurrent abortion, and women with secondary recurrent abortion show a tendency toward factor XII deficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969703     DOI: 10.1016/s0015-0282(03)00788-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.

Authors:  Eiji Matsukuma; Yoshimitsu Gotoh; Yoshiyuki Kuroyanagi; Takuji Yamada; Mitsuji Iwasa; Satoshi Yamakawa; Takuhito Nagai; Nobuaki Takagi; Hiromu Mae; Kenji Iijima; Elena Bresin
Journal:  Clin Exp Nephrol       Date:  2011-01-27       Impact factor: 2.801

Review 2.  Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature.

Authors:  A Girolami; N Zocca; B Girolami; A M Lombardi; F Fabris
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

3.  Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation.

Authors:  Sheng-Chieh Chou; Ching-Yeh Lin; Hsuan-Yu Lin; Chen-Hsueh Pai; Cheng-Ye Yu; Su-Feng Kuo; Jen-Shiou Lin; Po-Te Lin; Mei-Hua Hung; Han-Ni Hsieh; Hsiang-Chun Liu; Ming-Ching Shen
Journal:  Int J Hematol       Date:  2022-06-08       Impact factor: 2.319

Review 4.  Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.

Authors:  Min Li; S Joseph Huang
Journal:  Thromb Res       Date:  2009-08-14       Impact factor: 3.944

5.  A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis.

Authors:  Takayuki Iwaki; Mayra J Sandoval-Cooper; Harriet S Tenenhouse; Francis J Castellino
Journal:  J Am Soc Nephrol       Date:  2008-06-11       Impact factor: 10.121

6.  The procoagulant status. Hypercoagulability as a risk factor of primary and secondary infertility.

Authors:  Simona Daniela Neamţu; Liliana Stanca; Mirela Anişoara Siminel; Adela Valeria Neamţu; Adrian Gluhovschi; Garofiţa Olivia Mateescu; Anda Lorena Dijmărescu; Maria Sidonia Săndulescu; Anca Maria Istrate-Ofiţeru; Magdalena Rodica Trăistaru
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

7.  Factor XII (Hageman) levels in women with recurrent pregnancy loss.

Authors:  A Seval Ozgu-Erdinc; Cihan Togrul; Ayla Aktulay; Umran Buyukkagnici; Elif Gul Yapar Eyi; Salim Erkaya
Journal:  J Pregnancy       Date:  2014-11-12

8.  Factor XII deficiency in asymptomatic Saudi population: A retrospective cohort study.

Authors:  Fatmah S Alqahtany; Farjah H Algahtani; Mashael M Alshebly; Thamer S Albegamy; Essam S Alghamdi; Mohammed A Alnakhli; Fatimah M Madkhaly; Abdullah A Alharbi; Nawaf A Alqahtani
Journal:  Saudi J Biol Sci       Date:  2021-01-08       Impact factor: 4.219

9.  Hereditary factor XII deficiency in an adult patient: A case report.

Authors:  Rehab Y Al-Ansari; Fatimah Al-Yami; Ghayah Almulhim; Alexander Woodman
Journal:  SAGE Open Med Case Rep       Date:  2022-08-17

10.  Genotyping analysis for the 46 C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss.

Authors:  Eriko Asano; Takeshi Ebara; Chisato Yamada-Namikawa; Tamao Kitaori; Nobuhiro Suzumori; Kinue Katano; Yasuhiko Ozaki; Makoto Nakanishi; Mayumi Sugiura-Ogasawara
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.